Biome Grow Inc. (BIOIF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -742.68 Thousand | -1.83 Million | -2.06 Million | -2.22 Million | -4.62 Million | -2268.00 |
| Net Income | -10.88 Million | -139.92 Thousand | -1.71 Million | -9.48 Million | -8.86 Million | 185.61 Thousand |
| Depreciation & Amortization | - | - | - | 300.43 Thousand | 260.31 Thousand | - |
| Deferred income taxes | - | - | - | -265 Thousand | - | - |
| Stock-based compensation | 37.15 Thousand | 52.32 Thousand | 27.96 Thousand | 121.31 | 421.36 Thousand | - |
| Change in working capital | -141.01 Thousand | -786.28 Thousand | 2.59 Million | 1.29 Million | -385.04 Thousand | 53.41 Thousand |
| Other non-cash items | 10.24 Million | -965.71 Thousand | -2.97 Million | 243.51 Thousand | 3.94 Million | -241.3 Thousand |
| Investing Cash Flow | 261.15 Thousand | 2.16 Million | 565.22 Thousand | -1.74 Million | -3.41 Million | -1618.95 |
| Investments in PPE | - | - | - | -1.74 Million | -3.38 Million | -1618.95 |
| Acquisitions | - | - | - | - | -24.99 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 261.15 Thousand | 2.16 Million | 565.22 Thousand | - | - | - |
| Other Investing Activities | 261.15 | 2162.86 | 1808.17 | -1334.75 | 2408.00 | - |
| Financing Cash Flow | - | -309.55 Thousand | -2.29 Million | 4.17 Million | 6.82 Million | 2800.00 |
| Debt repayment | - | -240.28 Thousand | -3.56 Million | -4094.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -80 Thousand | 83.75 Thousand | 7.16 Million | - |
| Other Financing Activities | - | -69.26 Thousand | 1.34 Million | 4.09 Million | -346.88 Thousand | 5916.81 |
| Accounts receivables | -41.12 Thousand | -50.51 Thousand | -371.57 Thousand | -183.77 Thousand | -1.08 Million | -1033.00 |
| Accounts payables | - | -847.26 Thousand | 3.28 Million | 3.34 Million | 519.47 Thousand | - |
| Inventory | - | - | -3.28 Million | -1.71 Million | - | - |
| Other working capital | -99.89 Thousand | 111.48 Thousand | 2.96 Million | -146.66 Thousand | 180.75 Thousand | 54.45 Thousand |
| Cash at beginning of period | 583.2 Thousand | 569.49 Thousand | 2.06 Million | 1.85 Million | 3.07 Million | 747.00 |
| Cash at end of period | 101.67 Thousand | 583.2 Thousand | 569.49 Thousand | 2.06 Million | 1.85 Million | 1279.00 |
| Capital Expenditure | - | - | - | -1.74 Million | -3.38 Million | -1618.95 |
| Effect of forex changes on cash | - | - | 2.3 Million | - | -1.00 | - |
| Net cash flow / Change in cash | -481.53 Thousand | 13.7 Thousand | -1.49 Million | 205.3 Thousand | -1.21 Million | 532.00 |
| Free Cash Flow | -742.68 Thousand | -1.83 Million | -2.06 Million | -3.97 Million | -8 Million | -3886.95 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -195.32 | 53.16 Thousand | -264.29 Thousand | -10.88 Million | -1.72 Million | -598.59 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.62 | 2.28 | 2279.00 | 37.15 Thousand | 3799.00 | 8716.00 |
| Change in working capital | 39.18 | 146.12 Thousand | 6408.00 | -141.01 Thousand | 254.21 Thousand | 3918.00 |
| Other non-cash items | 135.08 | -298.11 Thousand | 102.22 Thousand | 10.24 Million | 1.42 Million | 485.64 Thousand |
| Investing Cash Flow | 33.57 | 44.62 Thousand | 87.51 Thousand | 261.15 Thousand | 1800.00 | 126.08 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 33.57 Thousand | 44.62 Thousand | 87.51 Thousand | 261.15 Thousand | 1800.00 | 126.08 Thousand |
| Other Investing Activities | 33.57 | 44.62 | 87.51 | 261.15 | 1.80 | 126.08 |
| Financing Cash Flow | -23.62 | -22.02 Thousand | 66.48 Thousand | - | - | - |
| Debt repayment | -22.59 Thousand | -22.02 Thousand | -23.67 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23.62 | -23.62 | 90.15 Thousand | - | - | - |
| Accounts receivables | - | - | - | -41.12 Thousand | -779.00 | -1453.00 |
| Accounts payables | - | - | - | - | - | 39.29 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 39.18 | 146.12 Thousand | 6408.00 | -99.89 Thousand | 254.99 Thousand | -33.92 Thousand |
| Cash at beginning of period | 26.06 | 102.28 Thousand | 101.67 Thousand | 583.2 Thousand | 139.99 Thousand | 114.23 Thousand |
| Cash at end of period | 19.57 | 26.06 Thousand | 102.28 Thousand | 101.67 Thousand | 101.67 Thousand | 139.99 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 6487.51 | 76.14 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -6.49 | -76.22 Thousand | 618.00 | -481.53 Thousand | -38.32 Thousand | 25.76 Thousand |
| Free Cash Flow | -16.45 | -98.82 Thousand | -153.37 Thousand | -742.68 Thousand | -40.12 Thousand | -100.32 Thousand |
ANRG
ZIMLAB
OVZON
ECOM
REMEDY
036630